XPO1 and nonpapillary renal cell carcinoma: Through similarity analysis and enrichment analysis, we observed that XPO1 could participate in multiple tumor progression signals in ccRCC, including E2F, PI3K-AKT, interferon-alpha, and TGF-beta signaling axes (Figure 7(e)).